‘It’s a thorny issue.’ Why a fight over DNA data imperils a global conservation pact
By Erik Stokstad,
Science
| 04. 05. 2022
For conservation biologists, the highest item on the global agenda this year is persuading the world’s nations to agree on new targets for saving nature. National leaders are scheduled to meet in China later this year to finalize a new strategic plan for the Convention on Biological Diversity (CBD), a 30-year-old global pact that sets decadal goals for preserving species and ecosystems. Last week, however, negotiators in Geneva reached an impasse. A major stumbling block is how the world should share billions of bits of genetic data stored on computers around the world.
The debate over these data—known as digital sequence information (DSI)—is new, but it echoes a long-standing point of contention. Developing nations that are rich in biodiversity, such as those in the tropics, have argued that more developed nations have exploited their natural heritage for commercial gain—for example, by using plants collected in the tropics to develop new crops or drugs—without sharing any of the revenue or benefits. That irks many parties, because a main objective of the CBD is to use the conservation of biodiversity to promote...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jonquilyn Hill, Vox | 10.18.2026
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...